Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics

The partnership combines Sciwind’s expertise in disease biology and clinical development capabilities with SynerK’s proprietary conjugate-based siRNA delivery technology and expertise in developing RNAi therapeutics SAN FRANCISCO, Calif. and HANGZHOU, China, Sept. 26, 2022 /PRNewswire/ –…